Investors in CVS Health Corp. (NYSE: CVS) will be looking for signs of improvement when the company's fourth-quarter and full-year earnings are released Wednesday morning ahead of the opening bell.

New York would become the first state to force pharmacy benefit managers to publicly reveal how much they profit from rebates issued by drug ...

Pharmacies across Oklahoma say they are losing hundreds of thousands of dollars because they say a company, CVS Caremark, is supposed to reimburse them for prescriptions and isn't holding up their end ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Elevance Health is the only health insurance company of 10 Moody's Ratings evaluated that received a "positive" credit ...

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...